東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

A history of drug regulation in the ...

Dowling College.

FindBook

Google Book

Amazon

博客來

A history of drug regulation in the United States 1902--2008: Effects on women's health.

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	A history of drug regulation in the United States 1902--2008: Effects on women's health./
作者:	Wessels-Cruz, Kathleen L.
面頁冊數:	231 p.
附註:	Adviser: Albert Inserra.
Contained By:	Dissertation Abstracts International69-04A.
標題:	Health Sciences, Pharmacy. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoeng/servlet/advanced?query=3313053
ISBN:	9780549616177

A history of drug regulation in the United States 1902--2008: Effects on women's health.
Wessels-Cruz, Kathleen L.

A history of drug regulation in the United States 1902--2008: Effects on women's health. - 231 p.

Adviser: Albert Inserra.

Thesis (Ed.D.)--Dowling College, 2008.

This study reviewed a history of drug research and regulation, federal policy, and pharmaceutical company involvement in the United States during the 20th century. The historical events that precipitated and formed legislation were analyzed.

ISBN: 9780549616177Subjects--Topical Terms:

1017737
Health Sciences, Pharmacy.

A history of drug regulation in the United States 1902--2008: Effects on women's health.
LDR:03266nam 2200337 a 45 001 854475
005 20100706
008 100706s2008 ||||||||||||||||| ||eng d
020 $a 9780549616177
035 $a (UMI)AAI3313053
035 $a AAI3313053
040 $a UMI $c UMI
100 1 $a Wessels-Cruz, Kathleen L. $3 1020859
245 1 2 $a A history of drug regulation in the United States 1902--2008: Effects on women's health.
300 $a 231 p.
500 $a Adviser: Albert Inserra.
500 $a Source: Dissertation Abstracts International, Volume: 69-04, Section: A, page: 1515.
502 $a Thesis (Ed.D.)--Dowling College, 2008.
520 $a This study reviewed a history of drug research and regulation, federal policy, and pharmaceutical company involvement in the United States during the 20th century. The historical events that precipitated and formed legislation were analyzed.
520 $a During the 20th century, clinical trials for testing the effects of a pharmacologic compound developed, as health events precipitated and legislation began to mandate their design. Women were excluded from clinical trials, both in the early part of the 1900s and later as clinical trials became more organized in the 1960s. The diethylstilbesterol and the thalidomide tragedies raised additional concern; in 1977, women were excluded from early phases of clinical drug trials because these drugs had resulted in death and deformity and raised public outcry for reform in the developing pharmaceutical industry.
520 $a Additionally, women were excluded from clinical testing for the fear that they might be or could become pregnant while in a clinical study, and that a particular drug might have an unknown teratogenic effect on a developing fetus. This study investigated drug research and regulation in the United States during the last century, covering the period from 1902--2008 and analyzed the effects of policy on the exclusion of women in clinical trials and the impact on women's health. There is evidence that pharmacologic compounds act differently in men and women. The therapeutic area of endocrinology and reproductive biology, were the focus, as incidents and regulation in these areas were pivotal throughout the last century. An analysis of past and present policies was performed with recommendations for the future. Additionally, current and emerging drug issues were reviewed, as they may impact women's health.
520 $a This study examined the progression of federal control and drug legislation, the events and tragedies that occurred, the effects that the legislation has had on the health of women and the nation, and the lack of the inclusion of women in clinical trials through a thorough review of public health policy, the Food and Drug Administration, and women's health issues during the twentieth century. This analysis provides an educational background for future policy makers, healthcare practitioners and for the women themselves.
590 $a School code: 1395.
650 4 $a Health Sciences, Pharmacy. $3 1017737
650 4 $a History, United States. $3 1017393
650 4 $a Political Science, Public Administration. $3 1017438
650 4 $a Women's Studies. $3 1017481
690 $a 0337
690 $a 0453
690 $a 0572
690 $a 0617
710 2 $a Dowling College. $3 1020858
773 0 $t Dissertation Abstracts International $g 69-04A.
790 $a 1395
790 1 0 $a Inserra, Albert, $e advisor
791 $a Ed.D.
792 $a 2008
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoeng/servlet/advanced?query=3313053